BerandaALKS • NASDAQ
add
Alkermes Plc
$31,78
Setelah Jam Perdagangan Normal:(0,00%)0,00
$31,78
Tutup: 2 Mei, 16.01.07 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$30,58
Rentang hari
$30,70 - $31,99
Rentang tahun
$22,90 - $36,45
Kapitalisasi pasar
5,24Â M USD
Volume Rata-Rata
1,94Â jt
Rasio P/E
14,45
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 429,99Â jt | 13,91% |
Biaya operasional | 205,18Â jt | -18,81% |
Laba bersih | 146,50Â jt | 29,90% |
Margin laba bersih | 34,07 | 14,02% |
Penghasilan per saham | 1,05 | 377,27% |
EBITDA | 169,54Â jt | 131,69% |
Tarif pajak efektif | 14,22% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 751,67Â jt | -2,82% |
Total aset | 2,06Â M | -3,78% |
Total liabilitas | 590,59Â jt | -36,74% |
Total ekuitas | 1,46 M | — |
Saham yang beredar | 162,61 jt | — |
Harga terhadap nilai buku | 3,39 | — |
Tingkat pengembalian aset | 19,32% | — |
Tingkat pengembalian modal | 25,43% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 146,50Â jt | 29,90% |
Kas dari operasi | 190,40Â jt | 77,55% |
Kas dari investasi | -13,88Â jt | 33,87% |
Kas dari pembiayaan | -281,67Â jt | -1,87% |
Perubahan kas bersih | -105,15Â jt | 44,73% |
Arus kas bebas | 122,70Â jt | 321,83% |
Tentang
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Didirikan
1987
Situs
Karyawan
1.800
